1. Xiao, Qianqian, Wang, Jing, Wang, Luyun, Ding, Hu. 2024. APOA1/C3/A4/A5 Gene Cluster at 11q23.3 and Lipid Metabolism Disorders: From Epigenetic Mechanisms to Clinical Practices. In Biomedicines, 12, . doi:10.3390/biomedicines12061224. https://pubmed.ncbi.nlm.nih.gov/38927431/
2. De Giorgi, Marco, Li, Ang, Hurley, Ayrea, Bao, Gang, Lagor, William R. 2021. Targeting the Apoa1 locus for liver-directed gene therapy. In Molecular therapy. Methods & clinical development, 21, 656-669. doi:10.1016/j.omtm.2021.04.011. https://pubmed.ncbi.nlm.nih.gov/34141821/
3. Fan, Lin, You, Yiwen, Fan, Yao, Shen, Chong, Xue, Yong. 2021. Association Between ApoA1 Gene Polymorphisms and Antipsychotic Drug-Induced Dyslipidemia in Schizophrenia. In Neuropsychiatric disease and treatment, 17, 1289-1297. doi:10.2147/NDT.S305200. https://pubmed.ncbi.nlm.nih.gov/33958870/
4. Supajaree, Pruttaya, Chanprasertyothin, Suwannee, Chattranukulchai Shantavasinkul, Prapimporn, Sritara, Piyamitr, Sirivarasai, Jintana. 2022. Association between ApoA1 Gene, Plasma Lipid Profile, hsCRP Level, and Risk of Arterial Stiffness in Thai Elderly. In Advances in preventive medicine, 2022, 4930033. doi:10.1155/2022/4930033. https://pubmed.ncbi.nlm.nih.gov/35873099/
5. Magray, Javid A, Pandith, Arshad A, Qasim, Iqbal, Ahmad, Ajaz, Wani, Mohammad S. 2021. Significant Implications of APOA1 Gene Sequence Variations and Its Protein Expression in Bladder Cancer. In Biomedicines, 9, . doi:10.3390/biomedicines9080938. https://pubmed.ncbi.nlm.nih.gov/34440141/